Analyst ratings, especially from reputable firms like Guggenheim, can significantly influence investor sentiment and stock prices. A reiterated Buy rating suggests that Guggenheim has a positive outlook on ADC Therapeutics, potentially leading to increased investor confidence and a positive short-term impact on the stock price.